Phosphoinositide 3-kinase gamma-deficient hearts are protected from the PAF-dependent depression of cardiac contractility.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Cardiovascular Research

• Publication date

  2003-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.CARDIORES.2003.08.008PMID 14613853
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phosphoinositide 3-kinase gamma is an essential amplifier of mast cell function.

  2002cited by this paper
• Phosphoinositide 3-Kinase γ Is an Essential Amplifier of Mast Cell Function

  2002cited by this paper
• Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways.

  2002cited by this paper
• Platelet-activating factor receptor.

  2002cited by this paper
• Negative inotropic mediators released from the heart after myocardial ischaemia-reperfusion.

  2002cited by this paper
• Seven-transmembrane-spanning receptors and heart function

  2002cited by this paper
• The phosphoinositide 3-kinase pathway.

  2002cited by this paper
• Resistance to thromboembolism in PI3Kγ‐deficient mice

  2001cited by this paper
• Phosphoinositide 3-Kinase Isoforms Selectively Couple Receptors to Vascular L-Type Ca2+ Channels

  2001cited by this paper
• A Specific Role of Phosphatidylinositol 3–Kinase γ

  2001cited by this paper
• PI3King the L-type calcium channel activation mechanism.

  2001cited by this paper
• Phosphoinositide 3-kinase isoforms selectively couple receptors to vascular L-type Ca(2+) channels.

  2001cited by this paper
• Resistance to thromboembolism in PI3Kgamma-deficient mice.

  2001cited by this paper
• Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattractant-mediated signal transduction.

  2000cited by this paper
• Platelet-activating factor and related lipid mediators.

  2000cited by this paper
• Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration.

  2000cited by this paper
• Therapeutic potential of platelet-activating factor antagonism in the management of myocardial infarction.

  2000cited by this paper
• The role of platelet-activating factor (PAF) antagonists and nitric oxide in cardiac actions of PAF. Electrophysiological and morphological study.

  2000cited by this paper
• Central role for G protein-coupled phosphoinositide 3-kinase γ in inflammation

  2000cited by this paper
• Roles of PLC-β2 and -β3 and PI3Kγ in Chemoattractant-Mediated Signal Transduction

  2000cited by this paper
• Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation.

  2000cited by this paper
• Role of platelet-activating factor in cardiovascular pathophysiology.

  2000cited by this paper
• erratum: Regulation of endothelium-derived nitric oxide production by the protein kinase Akt

  1999cited by this paper
• Platelet-activating factor acetylhydrolase prevents myocardial ischemia-reperfusion injury.

  1999cited by this paper
• Regulation of endothelium-derived nitric oxide production by the protein kinase Akt

  1999cited by this paper
• Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation

  1999cited by this paper
• Myocardial ischemia-reperfusion injury is exacerbated in absence of endothelial cell nitric oxide synthase.

  1999cited by this paper
• Contribution of NO to ischemia-reperfusion injury in the saline-perfused heart: a study in endothelial NO synthase knockout mice.

  1999cited by this paper
• Role of nitric oxide and platelet-activating factor in cardiac alterations induced by tumor necrosis factor-alpha in the guinea-pig papillary muscle.

  1999cited by this paper
• Role of nitric oxide and platelet-activating factor in cardiac alterations induced by tumor necrosis factor-α in the guinea-pig papillary muscle

  1999cited by this paper
• Interaction between neuronal nitric oxide synthase and inhibitory G protein activity in heart rate regulation in conscious mice.

  1998cited by this paper
• Phosphatidylinositol 3-kinase γ mediates shear stress-dependent activation of JNK in endothelial cells.

  1998cited by this paper
• Structure and function of phosphoinositide 3-kinases.

  1998cited by this paper
• The role of platelet-activating factor in regional myocardial ischemia-reperfusion injury.

  1998cited by this paper
• Generation of peroxynitrite contributes to ischemia-reperfusion injury in isolated rat hearts.

  1997cited by this paper
• Nitric oxide and cardiac function.

  1996cited by this paper
• Abnormalities of the myocytes in ischaemic cardiomyopathy.

  1995cited by this paper
• Platelet-activating factor receptor.

  1995cited by this paper
• Directions in antihypertensive treatment--our future from the past.

  1995cited by this paper
• Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase.

  1995cited by this paper
• Platelet-activating factor and WEB-2086 directly modulate rat cardiomyocyte contractility.

  1994cited by this paper
• Role of platelet activating factor in ischaemia-reperfusion injury of isolated rabbit hearts: protective effect of a specific platelet activating factor antagonist, TCV-309.

  1993cited by this paper
• Molecular cloning and characterization of the platelet-activating factor receptor gene expressed in the human heart.

  1992cited by this paper
• Role of platelet-activating factor in the reperfusion injury of rabbit ischemic heart.

  1990cited by this paper
• Release of platelet-activating factor from ischemic-reperfused rabbit heart.

  1989cited by this paper
• Effects of Damaging the Endocardial Surface on the Mechanical Performance of Isolated Cardiac Muscle

  1988cited by this paper

• Hypoxia Increases the Potential for Neutrophil-mediated Endothelial Damage in Chronic Obstructive Pulmonary Disease

  2022cites this paper
• activationide 3-kinase and protein kinase C isolated rat heart akin to ischemic preconditioning: role Platelet-activating factor induces cardioprotection in

  2016cites this paper
• Platelet Activating Factor in Heart Failure: Potential Role in Disease Progression and Novel Target for Therapy

  2013cites this paper
• PI3Kγ as a nodal point in μ-opioid receptor signaling

  2012cites this paper
• PI3K inhibitors in cardiovascular disease.

  2011cites this paper
• Platelet activating factor: the good and the bad in the ischemic/reperfused heart

  2011cites this paper
• Platelet-activating factor stimulates sodium-hydrogen exchange in ventricular myocytes.

  2011cites this paper
• A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.

  2008cites this paper
• Inhibition of PI3K improves contractility in alpha1-adrenergically stimulated myocardium.

  2008cites this paper
• Cardiac regulation by phosphoinositide 3-kinases and PTEN.

  2008cites this paper
• Study of molecular and immunological factors that determine the sensitivity to the antitumor effect of Tumor Necrosis Factor

  2008cites this paper
• PI3K&ggr; Is Required for PDE4, not PDE3, Activity in Subcellular Microdomains Containing the Sarcoplasmic Reticular Calcium ATPase in Cardiomyocytes

  2007cites this paper
• Sarcoplasmic Reticular Calcium ATPase in Cardiomyocytes Is Required for PDE 4 , not PDE 3 , Activity in Subcellular Microdomains Containing γ PI 3 K

  2007cites this paper
• Phosphoinositide 3-kinase gamma/delta inhibition limits infarct size after myocardial ischemia/reperfusion injury.

  2006cites this paper
• Promising though not yet proven: Emerging strategies to promote myocardial salvage

  2006influential citation
• Targeted inhibition of phosphoinositide 3-kinase activity as a novel strategy to normalize beta-adrenergic receptor function in heart failure.

  2006cites this paper
• Anaphylactic shock depends on PI3K and eNOS-derived NO.

  2006cites this paper
• PI3Kγ inhibition: towards an 'aspirin of the 21st century'?

  2006cites this paper
• PI3Kgamma inhibition: towards an 'aspirin of the 21st century'?

  2006cites this paper
• Phosphoinositide 3-kinase γ/δ inhibition limits infarct size after myocardial ischemia/reperfusion injury

  2006cites this paper
• Signalling pathways involved in insulin cardioprotection : are they comparable in normoxic perfused isolated rat heart vs. ischaemia/reperfusion model?

  2006cites this paper
• Cardiac Sarcoplasmic Reticulum Calcium Release and Load Are Enhanced by Subcellular cAMP Elevations in PI3K&ggr;-Deficient Mice

  2005cites this paper
• Cardiac Sarcoplasmic Reticulum Calcium Release and Load Are Enhanced by Subcellular cAMP Elevations in PI3K (cid:1) -Deficient Mice Cellular Biology

  2005cites this paper
• Recent advances in the understanding of the role of nitric oxide in cardiovascular homeostasis.

  2005cites this paper
• Signaling through PI3Kγ: a common platform for leukocyte, platelet and cardiovascular stress sensing

  2005cites this paper
• Protection from angiotensin II–mediated vasculotoxic and hypertensive response in mice lacking PI3Kγ

  2005cites this paper
• Platelet-activating factor induces cardioprotection in isolated rat heart akin to ischemic preconditioning: role of phosphoinositide 3-kinase and protein kinase C activation.

  2005cites this paper
• The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease.

  2004influential citation
• Phosphoinositide 3-kinase gamma: kinase-dependent and -independent activities in cardiovascular function and disease.

  2004cites this paper